JP2000504696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000504696A5 JP2000504696A5 JP1997528821A JP52882197A JP2000504696A5 JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5 JP 1997528821 A JP1997528821 A JP 1997528821A JP 52882197 A JP52882197 A JP 52882197A JP 2000504696 A5 JP2000504696 A5 JP 2000504696A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU8012 | 1996-02-12 | ||
| AUPN8012A AUPN801296A0 (en) | 1996-02-12 | 1996-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
| PCT/AU1997/000075 WO1997029767A1 (en) | 1996-02-12 | 1997-02-12 | Stabilised growth hormone formulation and method of preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000504696A JP2000504696A (ja) | 2000-04-18 |
| JP2000504696A5 true JP2000504696A5 (enExample) | 2004-11-18 |
| JP4255515B2 JP4255515B2 (ja) | 2009-04-15 |
Family
ID=3792327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52882197A Expired - Lifetime JP4255515B2 (ja) | 1996-02-12 | 1997-02-12 | 安定化された成長ホルモン処方物およびその製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6593296B1 (enExample) |
| EP (1) | EP0889733B1 (enExample) |
| JP (1) | JP4255515B2 (enExample) |
| CN (1) | CN1132626C (enExample) |
| AT (1) | ATE340587T1 (enExample) |
| AU (1) | AUPN801296A0 (enExample) |
| CA (1) | CA2246501C (enExample) |
| DE (1) | DE69736739T2 (enExample) |
| DK (1) | DK0889733T3 (enExample) |
| RU (1) | RU2191029C2 (enExample) |
| TR (1) | TR199801558T2 (enExample) |
| WO (1) | WO1997029767A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
| SK252002A3 (en) * | 1999-07-12 | 2002-06-04 | Grandis Biotech Gmbh | Growth hormone formulations |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| WO2001062296A2 (en) | 2000-02-24 | 2001-08-30 | Monsanto Technology Llc | Non-aqueous injectable formulations for extended release of somatotropin |
| AU2001271491A1 (en) | 2000-06-26 | 2002-01-08 | Monsanto Technology Llc | Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| GB2371227A (en) * | 2001-01-10 | 2002-07-24 | Grandis Biotech Gmbh | Crystallisation - resistant aqueous growth hormone formulations |
| JP4610154B2 (ja) * | 2002-05-30 | 2011-01-12 | 大塚製薬株式会社 | 注射用製剤 |
| ZA200505305B (en) * | 2002-12-31 | 2007-07-25 | Altus Pharmaceuticals Inc | Human growth hormone crystals and methods for preparing them |
| US20060252682A1 (en) * | 2003-03-18 | 2006-11-09 | Ares Trading S.A. | Liquid growth hormone formulation and process of preparation thereof |
| US20090029911A1 (en) * | 2003-09-25 | 2009-01-29 | Ashley Martin Williams | Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol |
| CA2551510C (en) * | 2003-12-23 | 2013-07-30 | Pharmacia Corporation | Stable growth hormone liquid formulation |
| AU2005237775B2 (en) * | 2004-04-07 | 2010-03-04 | Ares Trading S.A. | Liquid growth hormone formulation |
| CN101087805B (zh) | 2004-11-09 | 2012-05-23 | 阿雷斯贸易股份有限公司 | Fsh的纯化方法 |
| AU2005335900B2 (en) | 2005-08-26 | 2012-03-29 | Ares Trading S.A. | Process for the preparation of glycosylated interferon beta |
| JP5199112B2 (ja) | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| CN105363022A (zh) * | 2006-07-06 | 2016-03-02 | 株式会社大熊 | 稳定的人生长激素液体制剂 |
| LT2049148T (lt) * | 2006-07-06 | 2016-11-25 | Daewoong Co., Ltd. | Žmogaus augimo hormono skysta stabili kompozicija |
| KR101710471B1 (ko) * | 2008-04-21 | 2017-02-27 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 건조한 트랜스글루타미나제 조성물 |
| US20140194356A1 (en) * | 2011-07-25 | 2014-07-10 | Sandoz Ag | Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| US10064951B2 (en) * | 2012-03-30 | 2018-09-04 | Hanmi Science Co., Ltd. | Liquid formulation of highly concentrated long-acting human growth hormone conjugate |
| WO2015046974A1 (ko) * | 2013-09-27 | 2015-04-02 | 한미약품 주식회사 | 지속형 인간 성장 호르몬 제제 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB131864A (enExample) | ||||
| DE3325223A1 (de) * | 1983-07-13 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung |
| JPS6270319A (ja) * | 1985-07-30 | 1987-03-31 | インタ−ナシヨナル・ミネラルズ・アンド・ケミカル・コ−ポレイシヨン | 成長促進ホルモンの安定化 |
| IT1222395B (it) * | 1987-07-30 | 1990-09-05 | Pierrel Spa | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare |
| DE3782737T3 (de) | 1987-08-21 | 1999-05-20 | Imcera Group Inc., Northbrook, Ill. | Stabilisierung von Wachstumshormonen. |
| US5096885A (en) | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| EP0374120A3 (en) * | 1988-12-13 | 1991-07-31 | Monsanto Company | Comosition for controlled release of polypeptides |
| US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
| DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
| SE9201073D0 (sv) | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
| CA2337745C (en) * | 1992-07-31 | 2005-04-12 | Genentech, Inc. | Human growth hormone aqueous formulation |
| CZ290342B6 (cs) * | 1992-10-02 | 2002-07-17 | Genetics Institute Inc. | Kompozice stabilní při skladování, obsahující koagulační faktor VIII a neiontovou povrchově aktivní látku a způsob její výroby |
| AU685784B2 (en) * | 1993-02-23 | 1998-01-29 | Genentech Inc. | Excipient stabilization of polypeptides treated with organic solvents |
| US5707648A (en) * | 1993-11-17 | 1998-01-13 | Lds Technologies, Inc. | Transparent liquid for encapsulated drug delivery |
-
1996
- 1996-02-12 AU AUPN8012A patent/AUPN801296A0/en not_active Abandoned
-
1997
- 1997-02-12 EP EP97902109A patent/EP0889733B1/en not_active Revoked
- 1997-02-12 US US09/125,267 patent/US6593296B1/en not_active Expired - Fee Related
- 1997-02-12 TR TR1998/01558T patent/TR199801558T2/xx unknown
- 1997-02-12 DE DE69736739T patent/DE69736739T2/de not_active Expired - Lifetime
- 1997-02-12 CN CN97193316A patent/CN1132626C/zh not_active Expired - Fee Related
- 1997-02-12 DK DK97902109T patent/DK0889733T3/da active
- 1997-02-12 JP JP52882197A patent/JP4255515B2/ja not_active Expired - Lifetime
- 1997-02-12 CA CA2246501A patent/CA2246501C/en not_active Expired - Fee Related
- 1997-02-12 RU RU98117135/14A patent/RU2191029C2/ru active
- 1997-02-12 WO PCT/AU1997/000075 patent/WO1997029767A1/en not_active Ceased
- 1997-02-12 AT AT97902109T patent/ATE340587T1/de active